SEARCH

SEARCH BY CITATION

References

  • 1
    Mismetti P, Laporte-Simitsidis S, Tardy B et al. Prevention of thromboembolism in internal medicine with unfractioned or low-molecular-weight heparins: a meta-analysis of randomised clinical trials. Thromb Haemost 2000; 83: 149.
  • 2
    Samama MM, Cohen AT, Darmon JY et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med 1999; 341: 793800.
  • 3
    Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ; PREVENT Medical Thromboprophylaxis Study Group. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004; 110: 8749.
  • 4
    Cohen AT, Davidson BL, Gallus ASet al.; ARTEMIS Investigators. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ 2006; 332: 3259.
  • 5
    Leizorovicz A, Mismetti P. Preventing venous thromboembolism in medical patients. Circulation 2004; 110: IV139.
  • 6
    Chopard P, Dorffler-Melly J, Hess U et al. Venous thromboembolism prophylaxis in acutely ill medical patients: definite need for improvement. J Intern Med 2005; 257: 3527.
  • 7
    Haas S. Recommendations for prophylaxis of venous thromboembolism: International Consensus and the American College of Chest Physicians Fifth Consensus Conference on antithrombotic therapy. Curr Opin Pulm Med 2000; 6: 31420.
  • 8
    Bergmann JF, Elkharrat D. Prevention of venous thromboembolic risk in non-surgical patients. Haemostasis 1996; 26(Suppl. 2): 1623.
  • 9
    Scaglione L, Piobbici M, Pagano E, Ballini L, Tamponi G, Ciccone G. Implementing guidelines for venous thromboembolism prophylaxis in a large Italian teaching hospital: lights and shadows. Haematologica 2005; 90: 67884.
  • 10
    Vallano A, Arnau JM, Miralda GP, Perez-Bartoli J. Use of venous thromboprophylaxis and adherence to guideline recommendations: a cross-sectional study. Thromb J 2004; 2: 3.
  • 11
    Tapson VF, Decousus H, Piovella F et al., for the IMPROVE Investigators. A multinational observational cohort study in acutely ill medical patients of practices in prevention of venous thromboembolism: findings of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE). Blood 2003; 102: 1154 (abstract).
  • 12
    Kahn SR, Panju A, Geerts W et al., for the CURVE Study Investigators. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb Res 2006 (Epub ahead of print).
  • 13
    Bergmann JF, Mouly S. Thromboprophylaxis in medical patients: focus on France. Semin Thromb Hemost 2002; 28(Suppl. 3): 515.
  • 14
    Kucher N, Koo S, Quiroz R et al. Electronic alerts to prevent venous thromboembolism among hospitalised patients. N Engl J Med 2005; 352: 96977.
  • 15
    Durieux P, Nizard R, Ravaud P, Mounier N, Lepage E. A clinical decision support system for prevention of venous thromboembolism: effect on physician behavior. JAMA 2000; 283: 281621.
  • 16
    Stinnett JM, Pendleton R, Skordos L, Wheeler M, Rodgers GM. Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates. Am J Hematol 2005; 78: 16772.